To advance urgently needed research in Alzheimer's disease, FDA is engaging with researchers, drug companies, and the public as they design new clinical studies for promising drugs.
via FDA Consumer Health Information Updates http://ift.tt/2cBgoFC
No comments:
Post a Comment